Results

Total Results: 1,546 records

Showing results for "drug".

261. Antipsychotics-Children Research-Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/antipsychotics-children_research-protocol.pdf
     June 04, 2010 - Food and Drug Administration (FDA). … antipsychotic drug. … All formulations of drug delivery (e.g., tablet, liquid, injectable) and doses are eligible. … dose of the same antipsychotic drug. … National Library of Medicine’s TOXLINE® and MedEffectTM Canada Adverse Drug Reaction Database.

262. Evidence Report on the (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/rheumatoid-arthritis-medicine_research-protocol.pdf
     December 06, 2010 - Evidence-based Practice Center Systematic Review Protocol Project Title: Comparative Effectiveness of Drug … Food and Drug Administration (FDA) for the treatment RA at the time of the first review. … The Key Questions (KQs) Question 1: For patients with RA, do drug therapies differ in their ability … Question 3: For patients with RA, do drug therapies differ in harms, tolerability, patient adherence … Food and Drug Administration (FDA).

263. Evidence Summary for CER 239: Acute Treatments for Episodic Migraine (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/cer-239-acute-migraine-evidence-summary.pdf
     December 01, 2020 - Drug Healthc Patient Saf. 2018;10:37-43. doi: 10.2147/DHPS.S151073. PMID: 29760569. 13.

264. Evidence Report on the (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/arthritis-psoriatric_research-protocol.pdf
     December 06, 2010 - Evidence-based Practice Center Systematic Review Protocol Project Title: Comparative Effectiveness of Drug … Food and Drug Administration (FDA) to treat patients with PsA are adalimumab, etanercept, golimumab, … The first review did not include certolizumab pegol, golimumab, and tocilizumab drug therapies listed … KQ3: For patients with psoriatic arthritis, do drug therapies differ in harms, tolerability, adherence … Comparative Effectiveness of Drug Therapy for Rheumatoid Arthritis and Psoriatic Arthritis in Adults

265. Medical Care Journal Supplement (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/toc.pdf
     January 01, 2007 - Designed Delays Versus Rigorous Pragmatic Trials: Lower Carat Gold Standards Can Produce Relevant Drug … Studying Prescription Drug Use and Outcomes with Medicaid Claims Data: Strengths, Limitations, and … Developing Indicators of Inpatient Adverse Drug Events Through Non-Linear Analysis Using Administrative … Evaluation and Overview of the National Electronic Injury Surveillance System- Cooperative Adverse Drug

266. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/osteoporosis-bone-fracture_research-protocol.pdf
     May 14, 2010 - Food and Drug Administration (FDA) issued a warning in January 2008 linking the use of bisphosphonates … For titles obtained from the search for AEs by drug of interest, titles will be accepted if they suggest … that the manuscript includes information on the relationship between the AE and the drug. … Drug Labeling Change to Pamidronate (Aredia) Regarding Link to Renal Failure.

267. PREGNANCY, INCLUDING PRETERM BIRTH #12 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pregnancy-horizon-scan-high-impact-1512.pdf
     November 01, 2016 - dysplasia in preterm infants, interventions intended to target both the pregnant woman and fetus (a drug … AbbVie expects to complete pivotal trials by November 2016 and then submit a new drug application. … Food and Drug Administration approves elagolix, third-party payers may decline to cover the drug … Experts also noted that patients may prefer this oral drug over injectable alternatives. … elagolix.16,21 4 Acceptance and adoption: Clinicians may be more likely to prescribe an oral drug

268. Update Topic Brief CER 27 NSD FINAL_SJ final (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/type-2-diabetes-medications-update_overview.pdf
     January 17, 2014 - conclusions on comparative effectiveness of oral diabetes agents were out of date due to a newly approved drug … class (SGLT-2 inhibitors) and new evidence on previously reviewed drug classes.

269. DEMENTIA INCLUDING ALZHEIMER'S #04 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/dementia-horizon-scan-high-impact-1312.pdf
     December 01, 2013 - similar drugs in the same class are read separately), and then topics in the same class of a device, drug … Food and Drug Administration (FDA) recently approved two PET-imaging drugs for detecting beta-amyloid … ongoing clinical trials, intranasal delivery methods include needleless nostril syringes, a nasal drug … delivery methods have been used: needleless syringes inserted into alternating nostrils, a nasal drug … Exelon®), and tacrine (Cognex®) are FDA-approved cholinesterase inhibitors, and, depending on the drug

270. #14 SUBSTANCE ABUSE (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/substance-abuse-horizon-scan-high-impact-1412.pdf
     December 01, 2014 - Food and Drug Administration (FDA)-approved medication for reversing opioid overdose. … Food and Drug Administration (FDA) priority review for Evzio was based on evaluation of a series of … -based online aggregator of prescription-drug prices, lists retail prices for Evzio ranging from $588 … Food and Drug Administration (FDA), Center for Drug Evaluation and Research (CDER); 2014 Apr 3. … Food and Drug Administration (FDA); 2014 Apr 03 [accessed 2014 May 27]. [3 p].

271. Diabetes Mellitus (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/diabetes-horizon-scan-high-impact-1306.pdf
     January 01, 2016 - The drug/device has been approved in Europe. … Food and Drug Administration (FDA); 2012 Nov 9. 63 p. … Drug list search results: bydureon. [internet]. … FDA approves eye drug for diabetics. [internet]. … Drug formulary. [internet].

272. Diabetes Mellitus (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/diabetes-horizon-scan-high-impact-1312.pdf
     January 01, 2016 - Food and Drug Administration (FDA). … Food and Drug Administration (FDA). … Drug list search results: bydureon. [internet]. … FDA approves eye drug for diabetics. [internet]. … Drug formulary. [internet].

273. Horizon Scanning Protocol and Operations Manual January 2013 Revision (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/ahrq-healthcare-horizon-scan-protocol-operations-manual_130826.pdf
     August 01, 2013 - Is this a new molecular entity (drug), biologic, or device being developed for potential diffusion into … Is it subject to approval under FDA’s Investigational New Drug, Biologics Licensing, combination- product … Is it a generic drug? If so, do not select, because these are “me-too” of existing drugs. … Does this appear to be a different/off-label use of an available drug, biologic, or device? … Is this a different delivery mode for an existing drug or device?

274. Horizon-Scan Research-Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/horizon-scan_research-protocol.pdf
     December 01, 2011 - Is this a new molecular entity (drug), biologic, or generic formulation of a drug being developed for … Is it a generic drug? If so, do not select, because these are “me-too” of existing drugs. … Does this appear to be a different/off-label use of a currently available drug, biologic, or device? … Is this a different delivery mode for an existing drug or device? … Potential Device/Drug Cost Per Patient (if applicable) 12.

275. Fibromyalgia Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/fibromyalgia_executive.pdf
     January 01, 2015 - Twenty studies were drug trials (59%). … All eight pooled analyses of patient-level RCT data were drug studies. … Corresponding and other authors in drug trials were often industry employees. … Most drug trials were placebo-controlled RCTs. … Reporting issues were particularly prominent in drug studies.

276. Diabetes Mellitus (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/diabetes-horizon-scan-high-impact-1506.pdf
     June 01, 2015 - Weight loss over 39 weeks depended on drug dose. … Food and Drug Administration). … Food and Drug Administration (FDA). … Food and Drug Administration (FDA); 2012 Nov 9. 63 p. … Food and Drug Administration (FDA).

277. S3 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/s3.pdf
     October 01, 2007 - about the occurrence and outcomes of conditions that were being targeted by therapies in the Merck drug … Beyond pharmacoepide- miology: the larger role of epidemiology in drug development. … Exposure-time-varying hazard function ratios in case-control studies of drug effects. … Pharmacoepidemiol Drug Saf. 2006;15:81–92.

278. chronic-fatigue-protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/chronic-fatigue_research-protocol.pdf
     May 01, 2014 - Food and Drug Administration (FDA) approved medications for the treatment of ME/CFS, but many have … Food and Drug Administration’s (FDS’s) patient-focused drug development initiative, treatments fell … Center for Drug Evaluation and Research. … Food and Drug Administration's (FDA's) Patient-Focused Drug Development Initiative. … Food and Drug Administration; 2013.

279. Infectious Disease Including HIV/AIDS #09 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/infectiousdisease_hi_impact.pdf
     December 01, 2013 - Overall High Impact Potential: Xpert MTB/RIF test for detection and drug sensitivity testing of M. … Thus, intensive research has been ongoing with dozens of drugs in development in new drug classes. … Food and Drug Administration (FDA) because the material is prepared within the institution. … coverage and formulary status of the drug on the patient’s drug plan … Food and Drug Administration (FDA); 2011 Apr 5.

280. Pharmacotherapy for Adults With Alcohol-Use Disorders in Outpatient Settings: Systematic Review Update (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/alcohol-pharma-final-protocol.pdf
     January 01, 2023 - Medications most commonly used off label in the United States for adults with AUDs Drug Class Drug … National Survey on Drug Use and Health, Detailed Tables 2019. … Drug Alcohol Depend. 2006 Feb 1;81(2):149-55. doi: 10.1016/j.drugalcdep.2005.06.007. … Drug and alcohol abuse: a clinical guide to diagnosis and treatment. 6th ed. … Neurobiological basis of drug reinforcement.